- Home
- CDTX vs VNET Comparison
CDTX vs VNET Comparison
Compare CDTX & VNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- VNET
- Stock Information
- Founded
- CDTX 2012
- VNET 1999
- Country
- CDTX United States
- VNET China
- Employees
- CDTX N/A
- VNET N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- VNET Computer Software: Programming Data Processing
- Sector
- CDTX Health Care
- VNET Technology
- Exchange
- CDTX Nasdaq
- VNET Nasdaq
- Market Cap
- CDTX 2.8B
- VNET 2.4B
- IPO Year
- CDTX 2015
- VNET 2011
- Fundamental
- Price
- CDTX $219.75
- VNET $8.28
- Analyst Decision
- CDTX Buy
- VNET Strong Buy
- Analyst Count
- CDTX 13
- VNET 3
- Target Price
- CDTX $119.44
- VNET $13.20
- AVG Volume (30 Days)
- CDTX 2.2M
- VNET 4.8M
- Earning Date
- CDTX 11-06-2025
- VNET 11-20-2025
- Dividend Yield
- CDTX N/A
- VNET N/A
- EPS Growth
- CDTX N/A
- VNET N/A
- EPS
- CDTX N/A
- VNET N/A
- Revenue
- CDTX N/A
- VNET $1,335,622,122.00
- Revenue This Year
- CDTX N/A
- VNET $18.94
- Revenue Next Year
- CDTX N/A
- VNET $19.44
- P/E Ratio
- CDTX N/A
- VNET N/A
- Revenue Growth
- CDTX N/A
- VNET 20.19
- 52 Week Low
- CDTX $15.02
- VNET $3.46
- 52 Week High
- CDTX $220.32
- VNET $16.13
- Technical
- Relative Strength Index (RSI)
- CDTX 89.35
- VNET 37.78
- Support Level
- CDTX $102.46
- VNET $7.96
- Resistance Level
- CDTX $218.85
- VNET $8.98
- Average True Range (ATR)
- CDTX 4.30
- VNET 0.62
- MACD
- CDTX 12.80
- VNET -0.17
- Stochastic Oscillator
- CDTX 99.47
- VNET 12.70
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About VNET VNET Group Inc.
VNET started as AsiaCloud in 1999 and moved to the data center business with its first self-developed data center opening in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of June 2025, it had 51,960 retail cabinets with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 674 MW of wholesale capacity in service with a further 326 MW under construction and a further 792 MW held for future development.